Remove board Remove data collection Remove transportation Remove ventures
article thumbnail

All The Questions You Wanted Answered about Bird Scooters and Their Recent $300 Million Funding

Both Sides of the Table

Bird already has an enormous lead in data collection. Between our on-board CPUs and your mobile phone companions we have an enormous amount of data on transportation routes, where riders want to pick up scooters in the morning and where they leave them in the evening. Scooters crush this situation.

article thumbnail

Announcing the startups and judges onstage at TC Sessions: Mobility 2022

TechCrunch

The judges for this pitch-off will be Yoon Choi (Muirwoods Ventures), Mar Hershenson (Pear VC) and Gabriel Scheer (Elemental Excelerator) on day one; and Sven Strohband (Khosla Ventures), Victoria Beasley (Prelude Ventures) and John Du (GM Ventures) on day two. Yoon Choi — Muirwoods Ventures. Alright, alright.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Netradyne raises $150M in Series C to improve commercial driver safety

TechCrunch

A device that connects to the cloud is on board the vehicle, and it’s on the edge of that device that real-time computations are done, which might result in the driver getting feedback and automated suggestions like “please slow down” or “distracted driving.” . “If This Series C round was led by SoftBank Vision Fund 2.

article thumbnail

Parallel Domain says autonomous driving won’t scale without synthetic data

TechCrunch

Most self-driving vehicle companies, like Cruise, Waymo and Waabi, use synthetic data for training and testing perception models with speed and a level of control that’s impossible with data collected from the real world.

article thumbnail

‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M

TechCrunch

Eikon Therapeutics, co-founded by Betzig, is a biopharmaceutical company with plans to use super-resolution fluorescence microscopy, the data collected by these high-powered microscopes and a host of other tools to develop new drugs. . On Thursday, the company announced a $517.8 million Series B round.